Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (264)	3/16/1999 10:58:00 PM
From: LLCF	Read Replies (2) of 3158

< If these munchers are actually looking for something to sell, then Phase II won't really cut it.> You know it seems to me that companies with some decent science and a product or two would be fantastic purchases at these prices. I'm thinking of my two biggest holdings of course :) CORR & CEPH I mean look at these guys, CEPH is a dream come true if you bought it you could just cut out all the fat (fire the rat?), and bingo, cheap addition to your arsenal as well. With CORR, hell Integrelin is probably worth 2x with big Pharma what it's worth with CORR, lets face it! Who's going to sell more Integrelin CHIRON or CORR? Who's going to get Provigil approved for more indications, "MR. FDA" or big pharma? Any other ideas on this angle...? ALKS anyone? All these guys are looking for products... some are using HUGE market caps as targets as well, maybe someone will by 51% of CHIR? DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next